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Objective: To examine alcohol and drug use among random drivers in different regions of Norway by analyzing oral fluid, compare
drivers in urban and rural areas, compare with results from the roadside survey in southeastern Norway in 2005–2006, and roughly
estimate the prevalence of driving with blood drug concentrations above the new Norwegian legislative limits among random drivers.
This roadside survey was part of the European DRUID (Driving Under the Influence of Drugs, Alcohol and Medicines) Project.
Methods: Drivers were selected for a voluntary and anonymous study using a stratified multistage cluster sampling procedure in
collaboration with the Mobile Police Service. Samples of oral fluid were taken using the Statsure Saliva Sample (Statsure Diagnostic
Systems, Framingham, MA), and the drivers’ gender, age, and nationality were recorded. Samples of oral fluid were analyzed for
alcohol or drugs, for a total 28 psychoactive substances.
Results:One hundred eighty-four roadside survey sessions were conducted and 10,004 drivers were asked to participate. The refusal
rate was 5.8 percent. Psychoactive substances were found in 4.8 percent of the 9410 oral fluid samples analyzed. Alcohol was detected
in 0.3 percent, medicinal drugs in 3.2 percent, and illegal drugs in 1.5 percent of the samples. Illegal drugs were significantly more
frequently detected in samples from southeastern Norway including the capital Oslo, whereas medicinal drugs were more frequently
detected in samples from southeastern Norway excluding Oslo. Illegal drugs were significantly more frequently detected in samples
from drivers in urban areas than in rural areas, though there were no significant differences for alcohol andmedicinal drugs.Medicinal
drugs weremost commonly found in samples collected during the daytime onweekdays (3.8%), and illegal drugs weremost commonly
found in samples collected during late night on weekdays or weekends (2.8%–3.2%). The most commonly found substances were the
sleeping agent zopiclone (1.4%), the main active substance in cannabis tetrahydrocannabinol (1.1%), and the sedative drug diazepam
(0.7%). The prevalence of driving with drug concentrations above the Norwegian legislative limits for blood was estimated to be
about 0.2 percent for alcohol, 0.6 percent for illegal drugs, and about 1.3 percent for medicinal drugs.
Conclusions: The incidence of drink driving was very low, though driving after using psychoactive illegal or medicinal drugs was
more frequent.
Supplemental materials are available for this article. Go to the publisher’s online edition of Traffic Injury Prevention to view the
supplemental file.
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Introduction
It is well known that a large number of road traffic crashes
are related to the use of psychoactive substances, particularly
alcohol. Therefore, most countries have introduced legal lim-
its for alcohol, and some countries have zero tolerance laws
or impairment laws regarding driving under the influence of
psychoactive medicinal and illegal drugs.
A legal blood alcohol concentration (BAC) limit of 0.5 g/kg
blood (about 0.05 g/dL) was introduced in Norway in 1936,
Address correspondence to Hallvard Gjerde, Norwegian Insti-
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and the enforcement of the law has historically been strong
compared to many other countries; in 2008 more than 0.3 mil-
lion roadside breath alcohol tests per million inhabitants were
performed by the police in Norway (Jost et al. 2010). The pun-
ishment for drunkdrivingwas formanydecades unconditional
imprisonment for at least 3 weeks and suspended driver’s li-
cense for 2 years when driving with a BAC above the legal
limit. The legal limit was reduced to 0.2 g/kg blood (about
0.02 g/dL) in 2001, and the punishment was also moder-
ated. In February 2012, legislative limits were also introduced
for 20 other psychoactive substances (Vindenes et al. 2012).
The combination of low legal limits, strong enforcement, se-
vere punishment, and information campaigns hasmade drunk
driving socially unacceptable by the vast majority of the pop-
ulation (Assum 2010).
444 Gjerde et al.
The incidence of drunk driving in Norway has decreased
during the last decades. In the 1980s, 0.3 percent of the mo-
tor vehicle drivers had BACs above 0.05 g/dL (Glad 1985),
whereas in 2005–2006, about 0.1 percent of the drivers had
alcohol concentrations in oral fluid above 0.05 g/dL and 0.3
percent above 0.02 g/dL (Gjerde et al. 2008); the alcohol con-
centration in oral fluid has been shown to correspond closely
to the BAC (Jones 1979). A study organized by the European
Traffic Police Network (TISPOL) found that only 0.2 percent
of 32,000 Norwegian drivers had breath alcohol concentra-
tions above the legal limit (TISPOL 2009). On the other hand,
the number of blood samples from suspected drugged drivers
submitted for drug analysis by the police increased from about
2076 in 1989 to 4525 in 2008 (Edland-Gryt 2009), which is a
high number for a country with such a small population. The
high number is probably related to strong enforcement of driv-
ing under the influence laws.
A study of psychoactive substances in blood samples from
fatally injured car and van drivers in Norway in 2006–2008
found that 37.8 percent of the drivers had used alcohol
or drugs prior to the crash; alcohol concentrations above
0.02 g/dL were found in 25.0 percent of the samples, illicit
drugs in 10.2 percent, and psychoactive medicinal drugs in
13.8 percent of the samples. The prevalence of psychoactive
drugs in samples from drivers killed in single-vehicle acci-
dents was 64.3 percent, whereas the prevalence in samples
form drivers killed in multiple-vehicle crashes was 17.9 per-
cent (Gjerde, Christophersen et al. 2011).
We have previously studied the use of alcohol and drugs by
random drivers in southeastern Norway, excluding the capital
Oslo, during 2005–2006 (Gjerde et al. 2008). Alcohol or drugs
were found in 4.5 percent of the samples. Illegal drugs were
most frequently found among young male drivers, and medic-
inal drugs were most prevalent among elderly female drivers.
The new roadside survey of 2008–2009 was performed as
a part of the European DRUID project (DRUID Project) to
study the use of alcohol and drugs by drivers in 13 European
countries. The study was designed to compare the situation in
different countries and to calculate odds ratios for involvement
in traffic crashes after using alcohol and different drug classes
(Hels et al. 2011). The same analytical cutoff concentrations
(alcohol or drug concentrations above which a sample is re-
garded as positive) were used by all participating countries. In
order to enable a comparison of the drug prevalence in blood
samples with the prevalence in oral fluid samples, drug cutoff
concentrations were chosen so that the prevalence of positive
drug findings would be equal in samples of blood and oral
fluid from the studied population (also called equivalent cut-
offs; Gjerde and Verstraete 2011;Verstraete et al. 2011). For
some drugs, the cutoff concentration in oral fluid had to be
higher than in blood and for other drugs, lower. The analyti-
cal cutoffs were different from those used in previous studies
because of the requirement for equivalent cutoffs in oral fluid
and blood.
The aim of this report is to give an overview of the re-
sults from the Norwegian roadside survey of 2008–2009 to
supplement the results that already have been published in
the DRUID roadside survey reports (Bernhoft et al. 2012;
Houwing et al. 2011a, 2011b) and give a more in-depth
analysis. The cutoffs used in this report are equal to those
used in the study we performed in 2005–2006 (Gjerde et al.
2008), which was performed only in southeastern Norway, ex-
cluding the capital Oslo, and are for most substances lower
than those used in the DRUID roadside survey reports. The
study described in this article was performed in southeastern,
southwestern, middle, and northern Norway, and drivers in
Oslo were also included.
Methods
Study Design
Geographical Area
For practical and economical reasons, we could not perform
roadside sampling completely by random in such a sparsely
populated country as Norway, which has only 13 inhabitants
per square kilometer (34 per square mile). Therefore, 6 rep-
resentative regions were selected: 2 regions in southeastern
Norway (Hedmark and Romerike and Buskerud and Asker-
Bærum), 2 regions in southwestern Norway (Hordaland and
Haugaland), and 2 regions in middle and northern Norway
(Trøndelag andTroms); seeFigure 1. The selected regionswere
located in 5 of Norway’s 10 Mobile Police Service districts.
Oslo police gave the Mobile Police Service of surrounding
districts permission to stop drivers within Oslo.
Drivers were selected from April 2008 to March 2009 us-
ing a stratified multistage cluster sampling procedure. In the
first stage, representative police districts were selected. In the
Fig. 1. Map showing the study regions: 1, Troms; 2, Trøndelag;
3, Hordaland and Haugaland; 4, Buskerud and Asker-Bærum;
5, Hedmark and Romerike; 6, Greater Oslo area (color figure
available online).
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second stage, random road sites and time intervals were se-
lected according to a table of random sampling numbers
(Lindley and Miller 1966). The third stage consisted of ran-
domly stopping drivers. The data collection was carried out
in cooperation with the National Mobile Police Service of
Norway, which has the right to stop vehicles at random along
highways without any particular suspicion.
Roads were chosen by first randomly selecting map coor-
dinates within the study regions, weighted according to the
population in the area, and then choosing the roads closest
to the selected map coordinates. Road sites included both ur-
ban and rural roads but only within about 120 km from the
Mobile Police Service headquarters in Haugesund, Bergen,
Trondheim, and Tromsø and in southeastern Norway within
about 200 km of Oslo.
Time intervals were chosen by first randomly selecting a
period of 3 to 5 consecutive days for each police district for
each season of the year. For each day, the starting time for
roadside sampling was randomly selected. However, a few of
the selected time periods had to be changed to comply with
working time regulations for police officers. The time intervals
covered 7 days per week and 21 h per day (excluding the time
period from 3 a.m. to 6 a.m. due to working time regulations).
For each day, the police chose 2 road sites that were suitable
as checkpoints located within a 30- to 45-min drive from each
other. After stopping drivers at random for 2 h at the first
site, the personnel had a 1-h break during which they moved
to the second sampling site and continued sampling for 2 h.
If more cars passed the site than the police or the research
team could handle, the police were instructed to stop cars at
random, rather than stopping old cars, young drivers, or other
possible suspects of drugged driving.
Oral and written information about the project was given
to each driver; leaflets were available in 12 languages. After
an informed consent was obtained, a sample of oral fluid was
taken and a questionnaire was filled in. Participating drivers
did not receive any reward for taking part in the survey. The
study was approved by the Regional Committee for Medical
and Health Research Ethics.
Biological Samples
Samples of oral fluid were collected using Statsure Saliva Sam-
pler (Statsure Diagnostic Systems, Framingham, MA). The
oral fluid sampling kits were inspected visually, and kits that
did not contain any buffer or contained a too small volume of
buffer as observed visually were discarded (about 5%). When
sampling oral fluid, the collection pad was placed under the
tongue until the indicator turned blue or until 5 min had
passed. The vial was then capped and labeled with a bar code
label identical to the bar code of the questionnaire. The sample
was kept in a bag at a temperature of approximately 5◦C for a
maximum of about 6 h. Samples from southeastern Norway
were transported by car to the laboratory in Oslo and then
frozen at about −20◦C. Samples from other parts of Norway
were frozen locally at about −20◦C after each day of sam-
ple collection. Frozen samples were transported to Oslo by
airplane in well-insulated containers to prevent the frozen
samples from thawing during transport, and samples were
kept frozen at the laboratory until analysis.
Analysis of Oral Fluid
One day before the analysis of oral fluid started, samples were
thawed and weighed to determine the total amount of oral
fluid collected, and aliquots were pipetted into separate tubes
for analysis of alcohol and drugs. The concentrations of al-
cohol and drugs in undiluted oral fluid were calculated based
on the weight of oral fluid collected, assuming that 1.0 mL
buffer was present in the collection device. Analytical results
are expressed in nanograms per milliliter of undiluted (native)
oral fluid for drugs and in grams per deciliter for alcohol.
Alcohol was analyzed by an automated enzymatic method
using alcohol dehydrogenase (Kristoffersen and Smith-
Kielland 2005). Alcohol concentrations in oral fluid were
multiplied by 1.22 to obtain the corresponding concentra-
tion in blood (A. Verstraete et al., unpublished observations,
November 2009). Drug concentrations in oral fluid–buffer
mixtures were determined by liquid chromatography–tandem
mass spectrometry (Øiestad et al. 2007) using 3-point calibra-
tion. Analytical cutoff concentrations are presented in Table
A1 (see online Appendix) and are equal to those used in our
study performed in 2005–2006 (Gjerde et al. 2008). Samples
with drug concentrations above the linearity limits for the an-
alytical methods were diluted and reanalyzed.
Statistical Testing
Weighted prevalences of alcohol or drugs in samples of oral
fluid were calculated using PASW 17 statistical software (IBM
Corporation, Armonk, NY).
The participants were disaggregated into geographical
strata from 4 regions: (1) middle and northern Norway, (2)
southwest, (3) southeast except greater Oslo, and (4) the
greater Oslo area. The weighted prevalence was calculated
by first calculating the weight for the number of included
drivers in relation to the population as follows: let pa be
the reported population in regions a, a = 1, . . . , 4. The
4 pas add to 1. Furthermore, let n be the total number of
drivers and na be the number of included drivers in region
a. Preliminary weights wa were calculated such that the dis-
tribution of included drivers between regions in the weighted
sample matched the proportion of the population; that is, wa·
na/n= pa, givingwa = pa·n /na. Similarly, preliminary weights
vb, b = 1, . . . , 8 for time periods of the week were calculated
for each of the 4 regions; the 8 time periods were as follows:
(1) Monday to Friday 04:00 a.m. to 9:59 a.m.; (2) Monday
to Friday 10:00 a.m. to 3:59 p.m.; (3) Monday to Thursday
4:00 p.m. to 9:59 p.m.; (4) Monday to Thursday 10:00 p.m.
to 11:59 p.m. and Tuesday to Friday 12:00 a.m. to 3:59 a.m.;
(5) Saturday to Sunday 4:00 a.m. to 9:59 a.m.; (6) Saturday to
Sunday 10:00 a.m. to 3:59 p.m.; (7) Friday to Sunday 4:00 p.m.
to 9:59 p.m.; (8) Friday to Sunday 10:00 p.m. to 11:59 p.m. and
Saturday to Monday 12:00 a.m. to 3:59 a.m. Time periods 5
to 8 were defined as weekend. The final weights for all drivers
sampled in region a and time period b were given by wa·vb.
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Finally, let yabc indicate the result of a drug test on the cth
sampled driver in region a and time period b, where yabc = 1 if
the test is positive and 0 if it is negative. The prevalence of the
drug was then estimated by
∑
abcd(wa·vb ·yabc)/
∑
abcd(wa·vb).
Pearson’s 2-sided chi-square test for categorical data was
used and Wilson binomial confidence intervals (Wilson 1927)
were calculated incorporating continuity correction (Blyth
and Still 1983; Newcombe 1998) using weighted prevalences
and actual numbers of included drivers.
Estimation of cutoff concentrations in oral fluid corre-
sponding to those used for blood was performed as described
previously (Verstraete et al. 2011) using eithermean ormedian
oral fluid–to-blood ratios or prevalence regression (Gjerde and
Verstraete 2011). Approximate 95 percent confidence intervals
(CIs) for mean oral fluid–to-blood ratios were calculated as
follows: x′ ± 1.96·s/n 12 , where x′ is the sample mean, s is the
sample standard deviation, and n is the number of observa-
tions. Approximate 95 percent CIs for median oral fluid–to-
blood ratios were estimated by first calculating the confidence
interval quantiles p using the Wald method (Simonoff 2003):
p= p′ ± 1.96·[p′(1− p′)/n] 12 , where p′ for the median is 0.5 and
n is the number of observations. Approximate CIs for preva-
lence regression curves were calculated by regression analysis
using Microsoft Excel.
Results
Overview of Included Drivers
Altogether 184 roadside survey sessions were conducted, and
10,004 drivers were asked to provide a voluntary and anony-
mous sample of oral fluid. A total of 5.8 percent (583 drivers)
refused to provide a sample of oral fluid. The refusal rate var-
ied between different regions; in the southeast including Oslo,
6.2 percent; in the southwest, 6.7 percent; and in the middle/
north, 3.9 percent. The refusal rate was highest between 6 a.m.
and 10 a.m. (8.4% on weekdays and 9.4% on weekends) and
lowest on weekends between 10 a.m. and 4 p.m. (3.6%). We
were not allowed to collect any data on those who refused to
participate in the study.
Eleven samples contained less than 0.1 mL of oral fluid and
therefore could not be analyzed; those drivers were excluded.
In addition, 28 samples contained sufficient volume for one
method only (either alcohol or drugs); the analytical results
for those are included. Thus, data from a total of 9410 drivers
are included in this article, including 7992 car drivers, 1269 van
drivers, 80 truck drivers, and 69 motorcycle or moped drivers.
About 23 percent of the drivers were included in middle or
northern Norway, 20 percent from the southwest, 33 percent
from the southeast except Oslo, and 25 percent from greater
Oslo. As a comparison, in January 2001 about 24 percent of
the population lived inmiddle or northernNorway, 24 percent
in the southwest, 33 percent in the southeast, and 19 percent
in greater Oslo (Statistics Norway).
Twenty-nine percent of the drivers were female, which
roughly corresponds to the gender distribution of drivers in
general road traffic (Va˚gane 2005). Seven percent were of
foreign nationality. The age distribution was as follows:
younger than 25, 10.6 percent; 25 to 34, 17.9 percent; 35 to
44, 24.0 percent; 45 to 54, 21.3 percent; 55 to 64, 17.0 per-
cent; and older than 64, 9.2 percent. Age was not recorded
for 0.1 percent of the drivers. However, we also observed that
the distributions of age and gender among foreign drivers
were different from those for Norwegians. Among Norwegian
and foreign drivers, 51.3 and 68.0 percent were younger than
45 years of age, respectively, and 29.3 and 18.5 percent were
female.
Alcohol and Drug Findings
Analytical results above the analytical cutoff limits are pre-
sented in Table A1 (see online Appendix) and show that the
total prevalence of drivers who had recently used alcohol or
drugs was 4.8 percent. The prevalence of alcohol above the
cutoff of 0.01 g/dL was 0.3 percent, and the prevalence of
alcohol above the legal limit of 0.02 g/dL was 0.2 percent.
It is likely that the prevalence of alcohol and drugs among
drivers who refused to participate in this study was higher
than among the participants. The police detected 6 drunk
drivers who refused to provide oral fluid sample, which was
detected by the routine breath alcohol testing performed by
the police before referring the drivers to the study team. Those
drivers are not included in ourmaterial but correspond to 0.06
percent more positive alcohol findings than reported in this
article.
The use of defined cutoff concentrations is a systematic
way of reporting analytical results regardless of the capability
of the analytical methods (as long as the methods’ limits of
quantitation are lower than the cutoff concentrations) and en-
ables a comparison of findings with other studies. The cutoff
concentrations used in this study were equal to those used in
our roadside survey performed in 2005–2006 and are listed in
Table A1 (see online Appendix). Only results above the cut-
off are included in the data presented. The cutoffs for most
substances were lower than those used by the DRUID project
in the calculation of odds ratios for accident involvement and
for comparing drivers from different countries (Bernhoft et al.
2012; Hels et al. 2011; Houwing et al. 2011a, 2011b). The
weighting of results was also different from that used in the
DRUID project; in this article, weighting according to time
periods was performed for each geographical stratum sepa-
rately and, finally, weighting according to the populations in
geographical regions was performed.
The results presented in Tables 1–3 and Tables A2–A3 (see
online Appendix) represent findings of active drugs plus their
active or inactivemetabolites, thus reflecting a somewhatwider
time range than the active drug only.
Analytical results for drivers in urban and rural areas are
presented in Table 1 and show significantly higher prevalence
of the major illegal drugs in samples from urban areas than
rural areas (P = .003).
There were significant regional differences regarding use
of illegal and medicinal drugs (Table 2). The prevalence of
medicinal drugs was highest in samples from southeastern
Norway excluding Oslo, and the prevalence of illegal drugs
was highest in samples from southeastern Norway including
Oslo.
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Table 1.Weighted prevalence (and 95% CI) of alcohol and drugs in samples from drivers on urban and rural roads
Substance findings Urban Rural Total P
Total alcohol or drugs 5.2 (4.6–5.8) 4.5 (3.9–5.2) 4.8 (4.4–5.3) .100
Alcohol 0.4 (0.3–0.6) 0.3 (0.2–0.5) 0.3 (0.2–0.5) .394
Psychoactive medicinal drugs 3.3 (2.8–3.8) 3.1 (2.6–3.7) 3.2 (2.9–3.6) .623
Zopiclone 1.5 (1.2–1.9) 1.3 (1.0–1.7) 1.4 (1.2–1.7) .604
Benzodiazepines 1.8 (1.5–2.2) 1.4 (1.0–1.8) 1.6 (1.4–1.9) .168
Diazepam/nordiazepam 1.1 (0.8–1.4) 0.8 (0.6–1.1) 1.0 (0.8–1.2) .111
Codeine 0.3 (0.2–0.5) 0.6 (0.4–0.9) 0.4 (0.3–0.6) .056
Illegal drugs 1.9 (1.6–2.3) 1.1 (0.8–1.5) 1.5 (1.3–1.8) .003
Tetrahydrocannabinol 1.5 (1.2–1.9) 0.8 (0.6–1.1) 1.1 (0.9–1.4) .002
Amphetamines 0.4 (0.3–0.6) 0.2 (0.1–0.4) 0.3 (0.2–0.4) .209
Cocaine/benzoylecgonine 0.5 (0.3–0.7) 0.2 (0.1–0.4) 0.4 (0.3–0.6) .027
Total no. of samples analyzed 5163 4247 9410 —
The prevalence of medicinal drugs was higher in samples
collected between 6 a.m. and 4 p.m. during weekdays than
on weekends or at night (Table 3). Zopiclone was the most
frequently detected medicinal drug. It was most prevalent in
samples collected during weekday mornings, and the preva-
lence declined through the day. Alcohol and illegal drugs were
most prevalent in samples collected at night and early week-
end mornings. In samples collected between Friday 10 p.m.
and Saturday 4 a.m. and Saturday 10 p.m. to Sunday 4 a.m.
(n = 335), the prevalence of alcohol was 0.9 percent and the
prevalence of illegal drugs was 3.6 percent.
Significant differences were found between Norwegian and
foreign drivers (Table A2, see online Appendix). The preva-
lence of alcohol and illegal drugs was significantly lower
among Norwegian drivers, and the prevalence of medicinal
drugs was somewhat higher, although not statistically signifi-
cant.
Analytical results in relation to gender and age are pre-
sented in Figure 2 and show that illegal drugs were most often
found in samples from young men, whereas medicinal drugs
were most often found in samples from elderly women.
Analytical results for drivers in southeastern Norway from
the studies in 2005–2006 and 2008–2009 are presented in
(Table A3, see online Appendix). The same cutoff concen-
trations were used, and only drivers from the same police dis-
tricts were included. There were some differences, particularly
higher prevalence of benzodiazepines, tetrahydrocannabinol
(THC), and cocaine in the 2008–2009 study.
Estimation of Driving with Drug Concentrations Above
the New Legislative Limits
Drug concentrations in oral fluid cannot be used to accurately
estimate drug concentrations in blood for an individual; how-
ever, there is a positive correlation between drug concentra-
tions in oral fluid and blood (Gjerde et al. 2010; Verstraete
et al. 2011; Wille et al. 2009), which makes it possible to es-
timate drug use in a cohort; for example, the prevalence of
drug concentrations in blood above a given cutoff (Gjerde
and Verstraete 2010, 2011; Verstraete et al. 2011).
Norway implemented legislative limits for a number of
drugs in 2012. To estimate the prevalence of blood drug
concentrations above the legislative limits among the included
drivers, equivalent cutoff concentrations in oral fluid were
used. The use of equivalent cutoff concentrations in oral fluid
and blood will give the same prevalence of positive samples
if analyzing oral fluid or blood in a large cohort of drug
users. Paired samples of oral fluid and blood were used to
determine equivalent cutoffs; see Verstraete et al. (2011).
The equivalent cutoff concentrations in oral fluid and blood
are presented in Table 4 together with prevalence data. In
addition, mathematical simulations were used to estimate the
blood drug concentration distribution matching the obtained
drug concentrations in oral fluid using a previously published
procedure (Gjerde and Verstraete 2010). This procedure
cannot be used for small cohorts; therefore, we performed
this procedure only for diazepam, zopiclone, and THC.
Table 2.Weighted prevalence (and 95% CI) of alcohol and drugs in samples from drivers in different regions
Substance findings Greater Oslo Southeast except Oslo Southwest Middle/north P
Total alcohol or drugs 5.3 (4.4–6.3) 6.3 (5.5–7.2) 3.9 (3.1–4.9) 3.3 (2.6–4.1) .000
Alcohol 0.5 (0.3–0.9) 0.4 (0.2–0.7) 0.1 (0.0–0.4) 0.2 (0.1–0.5) .090
Psychoactive medicinal drugs 2.9 (2.3–3.7) 4.2 (3.5–5.0) 3.0 (2.3–3.9) 2.3 (1.7–3.1) .002
Zopiclone 1.5 (1.1–2.1) 1.8 (1.4–2.4) 1.5 (1.0–2.2) 0.6 (0.3–1.1) .004
Benzodiazepines 1.4 (1.0–2.0) 2.0 (1.5–2.6) 1.3 (0.9–1.9) 1.5 (1.0–2.1) .194
Diazepam/nordiazepam 0.9 (0.6–1.4) 1.2 (0.9–1.7) 0.7 (0.4–1.2) 1.0 (0.7–1.6) .378
Codeine 0.5 (0.3–0.9) 0.5 (0.3–0.8) 0.5 (0.2–1.0) 0.3 (0.1–0.6) .649
Illegal drugs 2.1 (1.6–2.8) 1.9 (1.5–2.5) 1.0 (0.6–1.6) 1.0 (0.7–1.6) .002
Tetrahydrocannabinol 1.5 (1.1–2.1) 1.3 (1.0–1.8) 0.7 (0.4–1.2) 0.9 (0.6–1.4) .047
Amphetamines 0.4 (0.2–0.8) 0.5 (0.3–0.8) 0.1 (0.0–0.4) 0.2 (0.1–0.5) .058
Cocaine/benzoylecgonine 0.7 (0.4–1.1) 0.6 (0.4–1.0) 0.1 (0.0–0.4) 0.0 (0.0–0.2) .000
Total no. of samples analyzed 2345 3061 1839 2165 —
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Table 3.Weighted prevalence (and 95% CI) of alcohol and drugs in samples from drivers at different times of the week
Weekday Weekday Weekday Weekday Weekenda Weekenda Weekenda Weekenda
6:00 a.m.– 10:00 a.m.– 4:00 p.m.– 10:00 p.m.– 6:00 a.m.– 10:00 a.m.– 4:00 p.m.– 10:00 p.m.–
Substance findings 9:59 a.m. 3:59 p.m. 9:59 p.m. 2:59 a.m. 9:59 a.m. 3:59 p.m. 9:59 p.m. 2:59 a.m. P
Total alcohol or drugs 5.8 (4.4–7.5) 5.9 (5.0–6.9) 4.2 (3.2–5.4) 4.1 (2.8–5.8) 4.3 (2.7–7.1) 4.1 (3.2–5.2) 3.2 (2.4–4.3) 6.0 (4.2–8.5) .003
Alcohol 0.6 (0.3–1.4) 0.3 (0.1–0.6) 0.2 (0.1–0.7) 0.2 (0.0–1.1) 0.0 (0.0–1.2) 0.8 (0.5–1.4) 0.0 (0.0–0.3) 0.9 (0.4–2.3) .004
Psychoactive medicinal drugs 3.6 (2.6–5.0) 4.8 (4.0–5.8) 2.7 (1.9–3.8) 1.8 (1.1–3.2) 2.9 (1.5–5.2) 2.5 (1.8–3.4) 1.9 (1.3–2.8) 2.8 (1.6–4.7) .000
Zopiclone 1.8 (1.1–2.9) 2.4 (1.8–3.1) 1.0 (0.6–1.8) 0.7 (0.2–1.6) 0.7 (0.0–2.5) 1.1 (0.7–1.8) 0.7 (0.4–1.4) 0.5 (0.1–1.8) .000
Benzodiazepines 1.2 (0.6–2.1) 2.0 (1.5–2.7) 1.7 (1.1–2.6) 1.4 (0.8–2.7) 2.2 (1.0–4.2) 1.2 (0.8–1.9) 1.0 (0.6–1.7) 2.3 (1.2–4.0) .216
Diazepam/nordiazepam 0.6 (0.3–1.4) 1.3 (0.9–1.9) 1.0 (0.6–1.8) 0.7 (0.2–1.6) 1.4 (0.5–3.2) 0.8 (0.5–1.4) 0.8 (0.4–1.4) 1.6 (0.7–3.1) .336
Codeine 0.7 (0.3–1.6) 0.6 (0.3–1.0) 0.2 (0.1–0.7) 0.2 (0.1–1.1) 0.0 (0.0–1.2) 0.3 (0.1–0.8) 0.4 (0.2–1.0) 0.5 (0.1–1.8) .373
Illegal drugs 1.6 (0.9–2.7) 1.0 (0.7–1.5) 1.5 (0.9–2.3) 3.2 (2.1–4.7) 2.9 (1.5–5.2) 1.1 (0.7–1.8) 1.5 (1.0–2.3) 2.8 (1.6–4.7) .002
Tetrahydrocannabinol 1.1 (0.5–2.0) 0.8 (0.5–1.3) 0.9 (0.5–1.6) 2.3 (1.4–3.6) 1.4 (0.5–3.2) 1.1 (0.7–1.8) 1.3 (0.8–2.0) 1.6 (0.7–3.1) .097
Amphetamines 0.1 (0.0–0.7) 0.3 (0.1–0.6) 0.2 (0.1–0.7) 0.9 (0.4–2.0) 1.4 (0.5–3.2) 0.3 (0.1–0.8) 0.2 (0.1–0.7) 0.9 (0.4–2.3) .005
Cocaine/benzoylecgonine 0.1 (0.0–0.7) 0.2 (0.1–0.5) 0.6 (0.3–1.2) 0.9 (0.4–2.0) 0.0 (0.0–1.2) 0.0 (0.0–0.3) 0.4 (0.2–1.0) 0.7 (0.2–2.1) .006
Total no. of samples analyzed 949 2381 1363 760 385 1628 1413 531 —
aWeekend was defined as Friday 4 p.m. until Monday 4 a.m.
Discussion
The key findings in this study were that psychoactive sub-
stances were found in 4.8 percent of oral fluid samples from
randomdrivers. Alcohol was detected in a relatively small pro-
portion of the samples (0.3%) compared to medicinal drugs
(3.2%) and illegal drugs (1.5%). Illegal drugs were significantly
more frequently detected in samples from drivers in urban ar-
eas than rural areas and in samples collected during late night
on weekdays or weekends.
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Fig. 2. Prevalence of alcohol, medicinal drugs, and illegal drugs
in samples from male and female drivers in relation to age (color
figure available online).
The DRUID roadside survey was primarily designed for
use in a case-control study to estimate odds ratios for the in-
volvement in road traffic crashes associated with the use of
different psychoactive substances. A second aim was to com-
pare the use of alcohol and drugs in different countries in
Europe. The cutoff concentrations used made it possible to
combine results from blood and oral fluid samples. Another
difference from most previous studies was that mutually ex-
clusive substance groups were reported, not total findings for
each substance (e.g., a sample being positive for THC and di-
azepam would not be counted as positive for those substances
but only for multiple drugs).
The aim of this article was to present a more in-depth anal-
ysis of the data on alcohol and drugs among randomdrivers in
Norway using the same cutoff concentrations thatwere used in
our first large roadside survey performed in 2005–2006 (Gjerde
et al. 2008). In that study, only drivers from southeastern
Norway excluding Oslo were included, and information about
road type (urban or rural) was not recorded. Therefore, our
new study provided important additional information com-
pared to the first one. The study design was also improved to
reduce the refusal rate, which was 12.0 percent in the study
in 2005–2006 and 5.8 percent in the new study, thus provid-
ing somewhat more reliable prevalence data. In the 2005–2006
study, the police informed the drivers about the study and to
ask them whether they would participate or not. If they were
willing to participate, the study team gave more detailed in-
formation. The improvement was simply that the police infor-
mation step was omitted and the study team asked the drivers
for participation, thus shortening the time required for each
participating driver to about 5 min.
In this study we also counted the number of drivers who
provided a positive breath alcohol test to the police but refused
to participate in our study. We also included motorcycle and
truck drivers, not just car and van drivers, as in the DRUID
project reports.
Geographical Differences
The results showed significant differences between urban
roads and rural roads and between regions of the country.
Samples from drivers in the most densely populated region
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Table 4. Estimated prevalence of alcohol and drug concentrations above the legislative limits in blood based on prevalence in oral
fluid samples including 95 percent CIs
Using equivalent cutoffs for blood and oral fluid
Mathematical
Legislative limit Equivalent cutoff simulation
in whole blood Formulaea in oral fluid Prevalence (%) Prevalence (%)
Substance (ng/mL) (95% CI for the slope) (ng/mL) (95% CI) (95% CI) (95% CIb)
Alcohol 0.02 g/dL — 0.02 g/dL (—) 0.2 (0.1–0.3) —
Medicinal drugs — — — 1.3 (1.0–2.0) —
Alprazolam 3 y = 0.350x (0.301–0.399) 1.1 (1.0–1.3) 0.04 (0.01–0.11) —
Clonazepam 1.3 y = 0.174x (0.159–0.190) 0.23 (0.21–0.25) 0.11 (0.06–0.22) —
Diazepam 57 y = 0.0392xc (0.0381–0.0403) 2.2 (2.2–2.3) 0.35 (0.24–0.50) 0.41 (0.21–0.61)
Flunitrazepam 1.6 y = 0.145xd (0.072–0.218) 0.23 (0.17–0.29) 0.04 (0.01–0.10) —
Methadone 25 y = 2.16x (1.48–2.85) 54 (37–71) 0.03 (0.01–0.10) —
Morphine 9 y = 9.50x (6.36–12.64) 86 (59–110) 0.02 (0.00–0.10) —
Nitrazepam 17 y = 0.0899x (0.036–0.143) 1.5 (1.1–2.0) 0.07 (0.02–0.19) —
Oxazepam 172 y = 0.264x (0.223–0.306) 45 (38–53) 0.06 (0.02–0.14) —
Zolpidem 31 y = 0.273x (0.251–0.319) 8.5 (7.8–9.9) 0.00 (0.00–0.05) —
Zopiclone 12 y = 2.52x (1.26–3.78) 30 (19–41) 0.63 (0.37–1.26) 0.64 (0.33–0.95)
Illegal drugs — — — 0.6 (0.4–0.8) —
Amphetamine 41 y = 18.0x (16.8–20.8) 740 (690–850) 0.07 (0.02–0.14) —
Cocaine 24 y = 20.5x (13.3–27.7) 490 (330–650) 0.03 (0.01–0.10) —
MDMAe 48 y = 13.6x (0–29) 650 (190–1100) 0.00 (0.00–0.05) —
Methamphetamine 45 y = 20.7x (15.5–23.2) 930 (700–1040) 0.11 (0.06–0.23) —
THC 1.3 y = 27.2x1.39 (21.2–34.9; 1.20–1.57) 39 (29–53) 0.49 (0.35–0.67) 0.79 (0.40–1.18)
aFormulae determined by the DRUID project (Verstraete et al. 2011); x = concentration in blood, y = concentration in oral fluid.
bA standard deviation of 25 percent was used for calculation of 95 percent CIs (Gjerde and Verstraete 2010).
cRecalculated formula using previous data generated by the DRUID project (Verstraete et al. 2011).
dBased on average oral fluid to blood concentration ratios from previously published data (Gjerde et al. 2010; Verstraete et al. 2011).
eMethylenedioxymethamphetamine; ecstacy.
(southeastern Norway including Oslo) were found to have a
higher prevalence of illegal drugs than samples obtained in
other regions of the country. The same tendency was found
when comparing samples fromdrivers stopped in urban versus
rural areas.We previously assumed that the use of illegal drugs
was more common in large cities, especially Oslo, than in rural
areas; our results confirmed this assumption. The incidence of
drink driving was very low in all of the studied regions of the
country and confirmed the finding in the roadside survey of
2005–2006 and the results from the TISPOL study of alcohol
use among random drivers (TISPOL 2009).
Age and Gender
The large differences between age groups and genders (Fig-
ure 2) confirmed previous findings fromNorway (Gjerde et al.
2008), and the trends were similar to results from other coun-
tries participating in the DRUID project (Houwing et al.
2011a).
Time of the Week
The prevalence of illegal drugs was higher among samples
collected at night than among those collected during the day,
but there was no marked difference between weekday and
weekend nights. Similar results were found for most other
countries participating in the DRUID project (Houwing et al.
2011a). The prevalence of alcohol seemed to be somewhat
higher on weekend nights (0.9%). Other countries have ob-
served more significant differences in the incidence of drunk
driving on weekend nights compared to other periods of the
week (Houwing et al. 2011a).
Medicinal drugs were more commonly found in samples
from drivers stopped during the daytime on weekdays than
in other time periods, similar to the results for other coun-
tries (Houwing et al. 2011a). In Norway, this seemed mainly
to be due to high prevalence of the sleeping agent zopiclone
at daytime. This was not unexpected because 6.4 percent of
the population had one or more prescriptions of zopiclone
dispensed from a pharmacy in 2008 (Rønning et al. 2009).
Caille et al. (1984) found a mean concentration in oral fluid
of about 2 ng/mL 24 h after administration of a therapeutic
dose of 7.5 mg of zopiclone. As an average, we would expect to
find zopiclone concentrations above the cutoff concentration
of 10 ng/mL for about 12 h after taking the tablet (Caille et al.
1984). As expected, we found that the prevalence of zopiclone
decreased through the day due tometabolism and elimination.
Despite the high prevalence of zopiclone, the odds ratio for
involvement in fatal accident associated with zopiclone use
was found to be low in a previous study (Gjerde, Normann,
Christophersen, Samuelsen, and Mørland 2011).
Norwegian Versus Foreign Drivers
When comparing Norwegian and foreign drivers, significant
differences were initially observed regarding the use of alco-
hol and illegal drugs (Table A2). For this comparison we also
weighted for age distribution and gender because a larger pro-
portion of foreign drivers were young and a larger proportion
were men. The differences between Norwegian and foreign
drivers were not unexpected; the European DRUID roadside
results showed that the prevalence of alcohol and illegal drugs
in samples from Norwegian drivers was significantly lower
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than in many other European countries (Bernhoft et al. 2012;
Houwing et al. 2011a).
Comparison with the 2005–2006 Study
The results from this study were compared with the former
study performed in 2005–2006 (Gjerde et al. 2008). There was
a significant increase in the prevalence of illegal drugs and
benzodiazepines and a possible decrease in the prevalence of
alcohol above 0.01 g/dL. Different geographical areas were
included in those 2 studies. However, significant differences
were also observed when comparing results from the same
geographical regions. One important difference between the
studies was the use of different oral fluid sampling devices. In
the first study, the Intercept sampling device was used. This
device stimulates the production of oral fluid and also changes
the pH locally in the mouth. This may affect the equilibrium
between drug concentration in oral fluid and blood, causing
the concentration either to increase or decrease. This is par-
ticularly important for basic compounds like amphetamines,
opiates, and cocaine and probably of less importance for neu-
tral compounds like benzodiazepines. The stimulation of oral
fluid production may also cause a dilution of the drug con-
centration, thereby lowering the prevalence of drug concen-
trations above cutoff. This effect is particularly important for
THC, because the detected THC in oral fluid is mainly caused
by residual THC from the oral cavity after smoking cannabis;
THC is distributed to a small extent from blood to oral fluid
(Niedbala et al. 2001). Therefore, the same type of sampling
device should be used when investigating changes in drug
use over time. However, the DRUID project team decided
that Statsure Saliva Sampler should be used by all participat-
ing countries based on a drug recovery study (Langel et al.
2008).
Statistically significant differences were observed between
the studies in 2005–2006 and 2008–2009 regarding THC, co-
caine, and benzodiazepines when comparing drivers in the
same geographical area. The difference for THC was proba-
bly mainly due to dilution of oral fluid combined with poor
recovery of THC from the Intercept device, which was used in
the 2005–2006 study. Studies have found a recovery of 38 per-
cent (Kauert et al. 2006; Øiestad et al. 2007) for the Intercept
device, whereas for the Statsure device the recovery was found
to be 85 percent (Langel et al. 2008).
For cocaine, alprazolam, and diazepam, no significant dif-
ferences in recoverywere observed (Langel et al. 2008). The use
of cocaine has been increasing in Norway in recent years; 3.5
and 4.3 percent of the drivers arrested for driving under influ-
ence of drugs were positive for benzoylecgonine (a metabolite
of cocaine) in 2005 and 2008, respectively (Edland-Gryt 2009).
Some increase in cocaine findings among random drivers was
therefore expected; however, a 7-fold increase is unlikely to
reflect the actual situation. The use of a sampling device that
stimulated salivation in the 2005–2006 study may also have
provided an incorrect low prevalence due to sample dilution.
For benzodiazepines there has also been an increase in findings
among arrested drivers drug between 2005 and 2008: about 23
percent for diazepam and 26 percent for clonazepam (Edland-
Gryt 2009). Thus, the increased prevalence of benzodiazepines
in samples from our latest study compared to the previous one
may at least partly be due to increased use among drivers.
The prevalence of alcohol above 0.01 g/dL was 0.5 percent
in the first study and 0.2 percent in the second one (P = .053,
a difference that is on the border of statistical significance).
This might be due to an actual reduction in the incidence
of driving after drinking alcohol, but it may also be due to
random variation or other reasons.
Comparison with Other Countries
Roadside surveys of alcohol or drug use among drivers have
also been performed in the United States (Lacey et al. 2009a,
2009b), Canada (Beirness andBeasley 2010),Australia (Davey
and Freeman 2009; Drummer et al. 2007), and Brazil (Pechan-
sky et al. 2010), in addition to those discussed in our previous
paper (Gjerde et al. 2008). A study was also performed in
Thailand using urine samples (Ingsathit et al. 2009), but it
is difficult to compare drug findings in urine with oral fluid
because drugs and their metabolites can be detected in urine
for a much longer time than in oral fluid after a single intake
(Verstraete 2004).
Studies at sobriety checkpoints in Brazil found that 22 to
38 percent of motor vehicle drivers at night on weekends had
been drinking, and about 20 percent had alcohol levels above
the legal limit corresponding to 0.06 g/dL in blood (Campos
et al. 2008; Duailibi et al. 2007). In a recent study covering 26
Brazilian state capitals and the Federal District, breath testing
of random drivers was performed between noon andmidnight
on Fridays and Saturdays. In total, 4.8 percent had detectable
alcohol on the breath, as did 7.3 percent of those driving after
8 p.m. (Pechansky et al. 2010).
In the United States, breath alcohol was detected in 12
percent of drivers at night on weekends, 4.5 percent with
findings corresponding to BACs above 0.05 g/dL (Lacey
et al. 2009a). In our study, 0.9 percent of the drivers at
night on weekends had BACs above 0.02 g/dL. In the Euro-
pean DRUID project, alcohol findings varied between coun-
tries. Theweighted prevalence of alcohol concentrations above
0.01 g/dL (total findings including combinations with drugs)
were about 9.6 percent in Italy, 6.7 percent in Belgium and
Portugal, 5.1 percent in Spain, 3.9 percent in Lithuania, and
lower in the remaining participating countries. On week-
end nights, the prevalence of alcohol concentrations above
0.05 g/dL were 8.2 percent in Italy, 6.3 percent in Belgium,
2.5 percent in Spain, and 2.0 percent in Lithuania (Houwing
et al. 2011a).
The incidence of drunk driving seems to be similar in Nor-
way, Sweden, and Finland (Bernhoft et al. 2012; TISPOL
2009). The DRUID study also found a low incidence of drunk
driving in Hungary, but this was not confirmed by TISPOL
data (TISPOL 2009).
As far as drugs are concerned, it is difficult to compare
different studies mainly because different cutoffs were used,
except for the DRUID project, where results using the same
cutoff concentrations for all 13 participating countries have
been published. In those study reports, the total prevalence for
each drug was not reported, onlymutually exclusive substance
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groups (Bernhoft et al. 2012; Houwing et al. 2011a, 2011b).
For some drugs, very high cutoffs were used—for example,
360 ng/mL for amphetamine, which is 18 times higher than
the recommended cutoff for drug driving studies (Walsh et al.
2008) and 14 times higher than the cutoff use in this article.
This cutoff is, in our opinion, too high to study the prevalence
of amphetamine use among drivers, but it can be used in
studies where results for blood and oral fluid are combined.
Driving with Drug Concentrations Above the
New Legislative Limit
An estimation of the proportion of random drivers who had
blooddrug concentrations above the new legal limitswasmade
using oral fluid. Therefore, the estimates must not be regarded
as accurate. We also present approximate 95 percent CIs for
the estimations. The mathematical simulation method could
be used only for the most prevalent drugs because about 100
positive samples are needed to obtain acceptable accuracy
of the simulation. The estimations for diazepam, zopiclone,
and THC obtained when using mathematical simulation were
similar to those obtained when equivalent cutoffs were used.
The legal limits for drugs were set to correspond to one
fifth of the observed concentration in whole blood after tak-
ing a typical recreational and inebriating dose of the drug
(Vindenes et al. 2012). Therefore, the data presented in Ta-
ble 4 reflect which drugs most frequently cause impaired driv-
ing among drivers in normal traffic. Our estimations showed
that zopiclone, THC, and diazepam (in that order) were the 3
most common drugs present in concentrations above the legal
limits among random drivers.
We found that driving with a BAC above 0.02 g/dLwas less
prevalent (0.2%) than driving with blood drug concentrations
above the legal limits for zopiclone, THC, and diazepam. In
total, our findings suggest that about 1.3 and 0.6 percent of
the drivers had concentrations of medicinal drugs and illegal
drugs above the legal limits, respectively. These findings are
similar to our previous estimation based on a roadside survey
performed in southeasternNorway in 2005–2006 (Gjerde et al.
2008), where we estimated that 1.1 and 0.4 percent of the
drivers had blood concentrations above the new legal limits for
medicinal and illegal drugs, respectively (Gjerde, Normann,
Christophersen, and Mørland 2011).
According to the revised Norwegian driving under the in-
fluence law, a driver with a concentration of a medicinal drug
in blood exceeding the legal limit is not necessarily convicted
if the driver obtained the drug through a prescription and
the concentration was within the therapeutic range and the
driver did not show any indication of impairment. Therefore,
a large proportion, probably the vast majority, of those with
concentrations of medicinal drugs above the legislative limits
would not be convicted of drug driving.
Conclusion
Illegal drugs were more frequently found in samples of oral
fluid obtained from car and van drivers in urban areas than
in rural areas and more frequently found in samples from
drivers in southeasternNorway including the capitalOslo than
in other parts of the country. There was an increase in use
of cocaine and benzodiazepines among drivers compared to
the results of the roadside survey of 2005–2006. Driving with
alcohol concentrations above the legal limit was less frequent
than driving with concentrations of illegal drugs above the
new legal limits, and driving with medicinal drugs above the
legal limits was even more frequent. In total, the incidence of
driving under the influence of alcohol or drugs in Norway was
less frequent than in many other countries.
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